Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

Birtle, A., Johnson, M., Chester, J. et al. (21 more authors) (2020) Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. The Lancet, 395 (10232). pp. 1268-1277. ISSN 0140-6736

Abstract

Metadata

Authors/Creators:
  • Birtle, A.
  • Johnson, M.
  • Chester, J.
  • Jones, R.
  • Dolling, D.
  • Bryan, R.T.
  • Harris, C.
  • Winterbottom, A.
  • Blacker, A.
  • Catto, J.W.F. ORCID logo https://orcid.org/0000-0003-2787-8828
  • Chakraborti, P.
  • Donovan, J.L.
  • Elliott, P.A.
  • French, A.
  • Jagdev, S.
  • Jenkins, B.
  • Keeley, F.X.
  • Kockelbergh, R.
  • Powles, T.
  • Wagstaff, J.
  • Wilson, C.
  • Todd, R.
  • Lewis, R.
  • Hall, E.
Copyright, Publisher and Additional Information: © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Dates:
  • Accepted: 11 February 2020
  • Published (online): 5 March 2020
  • Published: 18 April 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 20 Mar 2020 15:53
Last Modified: 06 Dec 2021 16:39
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/s0140-6736(20)30415-3

Share / Export

Statistics